Hypercoagulability may contribute to stroke in young adults. Lupus anticoagulants (LA) were
identified in six patients (4%) of 145 young adults with cerebral infarction. The clinical …

25 patients with lupus anticoagulant (LA) and a history of thrombosis are described and the
cases reported in the literature with this association are reviewed. From the combined data it …

In a controlled, prospective study of 44 consecutive women with idiopathic habitual abortion,
only 5% had symptoms of rheumatic disease. Patients did not differ from control subjects in …

Two young adults with lupus anticoagulant had multiple attacks of cerebrovascular ischemia
in different arterial territories. Cerebral angiography was normal. One patient had a new …

• Thirty-five patients with the lupus anticoagulant (LA) were followed up between 1975 and
1982. The most prevalent clinical manifestation occurring in these patients was thrombosis …

The lupus anticoagulant, an acquired circulating serum gamma-globulin, prolongs all
phospholipid-dependent coagulation tests. Recent associations of the lupus anticoagulant …

A 35-year old man with lupus erythematosus of the skin is demonstrated, who also shows
signs of systemic LE: sometimes slightly increased ESR, varying thrombocytopenia, slightly …

Systemic lupus erythematosus is often complicated by a circulating anticoagulant, yet
serious hemorrhage is rare in patients with this complication. It has also been observed that …

To define clinical and laboratory characteristics of the lupus anticoagulant (LA), we reviewed
our experience (219 subjects). Subjects were divided into group A, those with the LA and the …

The clinical and laboratory experience with the lupus anticoagulant was reviewed in 37
patients. The anticoagulant is thought to act by blocking the activation of prothrombin by the …